Vera Therapeuticsincis A Clinical Stage Biotechnology Company Based In Brisbanecaliforniafounded In 2016The Company Focuses On Developing Innovative Treatments For Patients With Serious Immunological Diseasesits Mission Is To Change The Standard Of Care For These Patients By Creating Novel Biologic Molecules That Address Significant Unmet Medical Needs The Company Has Several Key Products In Its Pipelineatacicept Is Its Lead Candidatedesigned To Treat Iga Nephropathya Kidney Diseasethrough A Subcutaneous Autoinjectormau868 Is A Monoclonal Antibody Aimed At Neutralizing Bk Virus Infections In Kidney Transplant Patientshaving Shown Effectiveness In Clinical Trialsadditionallyvt 109 Is A Dual Inhibitor Molecule Intended For Treating Autoimmune Diseasesvera Therapeutics Went Public In May 2021 And Employs Around 112 Peopleled By Ceo Marshall Fordyce
No conferences found for this company.
| Company Name | Vera Pharma |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
